Lenvatinib Capsules IP 4 MG

Lenvatinib Capsules IP 4 MG Specification

Pacakaging (Quantity Per Box)
3 x 10 Capsules

Salt Composition
Lenvatinib

Physical Form
Capsules

Recommended For
Thyroid Cancer

Dosage
4 mg

Dosage Guidelines
As per suggestion

Storage Instructions
Dry place

Lenvatinib Capsules IP 4 MG Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Lenvatinib Capsules IP 4 MG

Lenvatinib Capsules IP 4 mg is a medication that is recommended for the treatment of thyroid cancer. It contains Lenvatinib as the active ingredient which works by inhibiting the growth of cancer cells. The capsules come in a packaging of 3 x 10 capsules and have to be stored in a dry place. The dosage guidelines for the medication should be followed as per the suggestions of the healthcare provider. This medication is only available as a prescription drug and should not be taken without consulting a doctor. It should be taken regularly and on time for the best results. The capsules are to be swallowed whole with water and should not be crushed or chewed. If you experience any side effects or allergic reactions, seek medical attention immediately. The medication should not be taken during pregnancy or breastfeeding.

FAQs of 4 MG Lenvatinib Capsules IP:

Q: What is Lenvatinib Capsules IP 4 mg used for?

A: Lenvatinib Capsules IP 4 mg is recommended for the treatment of thyroid cancer.

Q: How should the medication be taken?

A: The medication should be taken as per the dosage guidelines provided by the healthcare provider. The capsules should be swallowed whole with water and should not be crushed or chewed.

Q: What are the possible side effects of the medication?

A: Some possible side effects of the medication include nausea, vomiting, diarrhea, loss of appetite, headache, fatigue, and high blood pressure. If you experience any side effects or allergic reactions, seek medical attention immediately.